230.80
5.20 (2.30%)
| Penutupan Terdahulu | 225.60 |
| Buka | 225.80 |
| Jumlah Dagangan | 17,078,898 |
| Purata Dagangan (3B) | 7,343,182 |
| Modal Pasaran | 4,802,001,408 |
| Harga / Pendapatan (P/E TTM) | 28.85 |
| Harga / Pendapatan (P/E Ke hadapan) | 17.83 |
| Harga / Jualan (P/S) | 2.73 |
| Harga / Buku (P/B) | 3.53 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Jul 2025 |
| Hasil Dividen (DY TTM) | 0.03% |
| Margin Keuntungan | 8.32% |
| Margin Operasi (TTM) | 16.55% |
| EPS Cair (TTM) | 0.070 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 8.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 50.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 71.18% |
| Nisbah Semasa (MRQ) | 1.55 |
| Aliran Tunai Operasi (OCF TTM) | 396.20 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 309.75 M |
| Pulangan Atas Aset (ROA TTM) | 6.06% |
| Pulangan Atas Ekuiti (ROE TTM) | 11.27% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (GB) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Menurun | Menurun | |
| Stok | CONVATEC GROUP PLC ORD 10P | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -2.5 |
| Purata | -0.63 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| CONVATEC GROUP PLC ORD 10P | 5 B | 0.03% | 28.85 | 3.53 |
| BECTON DICKINSON AND CO BECTON | 47 B | 2.15% | 27.35 | - |
| RESMED INC RESMED ORD SHS | 35 B | 0.79% | 47.35 | - |
| HOLOGIC INC HOLOGIC ORD SHS | 16 B | - | 10.10 | - |
| COOPER COMPANIES INC COOPER ORD | 4 B | - | 4.31 | - |
| TECAN GROUP AG TECAN GROUP ORD | 2 B | 1.87% | 16.50 | - |
|
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 19.75% |
| % Dimiliki oleh Institusi | 64.80% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |